Bruker Corporation $BRKR Shares Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its position in shares of Bruker Corporation (NASDAQ:BRKR) by 19.9% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 306,396 shares of the medical research company’s stock after buying an additional 50,955 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Bruker were worth $11,055,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Los Angeles Capital Management LLC acquired a new position in Bruker in the 4th quarter valued at $26,000. Parallel Advisors LLC boosted its holdings in shares of Bruker by 121.0% during the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock worth $41,000 after purchasing an additional 479 shares during the last quarter. Allworth Financial LP boosted its holdings in shares of Bruker by 40.6% during the third quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after purchasing an additional 257 shares during the last quarter. Summit Securities Group LLC purchased a new stake in shares of Bruker in the fourth quarter valued at $50,000. Finally, Covestor Ltd grew its position in shares of Bruker by 304.6% in the fourth quarter. Covestor Ltd now owns 1,416 shares of the medical research company’s stock valued at $67,000 after purchasing an additional 1,066 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Stock Performance

Shares of NASDAQ:BRKR opened at $59.74 on Thursday. The firm has a market capitalization of $9.09 billion, a PE ratio of -248.92, a P/E/G ratio of 1.93 and a beta of 1.29. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.55 and a quick ratio of 0.72. The business has a 50-day moving average of $55.61 and a two-hundred day moving average of $46.12. Bruker Corporation has a 12 month low of $28.53 and a 12 month high of $64.54.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Wednesday, May 6th. The medical research company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.08. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.The business had revenue of $823.40 million for the quarter, compared to analyst estimates of $795.62 million. During the same period in the previous year, the company posted $0.47 EPS. The company’s revenue was up 2.7% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, research analysts forecast that Bruker Corporation will post 2.12 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 7th. Investors of record on Monday, June 22nd were issued a $0.05 dividend. The ex-dividend date was Monday, June 22nd. This represents a $0.20 annualized dividend and a yield of 0.3%. Bruker’s dividend payout ratio (DPR) is presently -83.33%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Leerink Partners increased their target price on Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 7th. Wolfe Research assumed coverage on Bruker in a report on Monday, June 1st. They issued a “peer perform” rating for the company. Weiss Ratings raised shares of Bruker from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. TD Cowen reiterated a “hold” rating on shares of Bruker in a report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. raised their target price on shares of Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $56.79.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.